Details
Stereochemistry | RACEMIC |
Molecular Formula | C11H15BrN2O3 |
Molecular Weight | 303.152 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C1(CC(Br)=C)C(=O)NC(=O)N(C)C1=O
InChI
InChIKey=WGMASVSHOSNKMF-UHFFFAOYSA-N
InChI=1S/C11H15BrN2O3/c1-6(2)11(5-7(3)12)8(15)13-10(17)14(4)9(11)16/h6H,3,5H2,1-2,4H3,(H,13,15,17)
Enibomal (narcobarbital) is a barbiturate drug. By its chemical structure, it is N-methylated derivative of propallynolal. Narcobarbital was discovered in 1930s and later investigated as an anesthetic agent in gynecological surgery and electroconvulsive treatment. In the United States, narcobarbital is classified as a schedule III drug and is not found in pharmaceutical preparations. In Europe, narcobarbital was used in veterinary as a general anesthetic for pigs, but by 2000 it was withdrawn and no longer available at the market.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
N01AG01
Created by
admin on Sat Dec 16 01:28:25 GMT 2023 , Edited by admin on Sat Dec 16 01:28:25 GMT 2023
|
||
|
WHO-VATC |
QN01AG01
Created by
admin on Sat Dec 16 01:28:25 GMT 2023 , Edited by admin on Sat Dec 16 01:28:25 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL92963
Created by
admin on Sat Dec 16 01:28:25 GMT 2023 , Edited by admin on Sat Dec 16 01:28:25 GMT 2023
|
PRIMARY | |||
|
Narcobarbital
Created by
admin on Sat Dec 16 01:28:25 GMT 2023 , Edited by admin on Sat Dec 16 01:28:25 GMT 2023
|
PRIMARY | |||
|
125-55-3
Created by
admin on Sat Dec 16 01:28:25 GMT 2023 , Edited by admin on Sat Dec 16 01:28:25 GMT 2023
|
PRIMARY | |||
|
m837
Created by
admin on Sat Dec 16 01:28:25 GMT 2023 , Edited by admin on Sat Dec 16 01:28:25 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB13672MIG
Created by
admin on Sat Dec 16 01:28:25 GMT 2023 , Edited by admin on Sat Dec 16 01:28:25 GMT 2023
|
PRIMARY | |||
|
C010308
Created by
admin on Sat Dec 16 01:28:25 GMT 2023 , Edited by admin on Sat Dec 16 01:28:25 GMT 2023
|
PRIMARY | |||
|
3791
Created by
admin on Sat Dec 16 01:28:25 GMT 2023 , Edited by admin on Sat Dec 16 01:28:25 GMT 2023
|
PRIMARY | |||
|
18735
Created by
admin on Sat Dec 16 01:28:25 GMT 2023 , Edited by admin on Sat Dec 16 01:28:25 GMT 2023
|
PRIMARY | |||
|
DB13229
Created by
admin on Sat Dec 16 01:28:25 GMT 2023 , Edited by admin on Sat Dec 16 01:28:25 GMT 2023
|
PRIMARY | |||
|
A77U8G9H84
Created by
admin on Sat Dec 16 01:28:25 GMT 2023 , Edited by admin on Sat Dec 16 01:28:25 GMT 2023
|
PRIMARY | |||
|
DTXSID30871609
Created by
admin on Sat Dec 16 01:28:25 GMT 2023 , Edited by admin on Sat Dec 16 01:28:25 GMT 2023
|
PRIMARY | |||
|
100000079500
Created by
admin on Sat Dec 16 01:28:25 GMT 2023 , Edited by admin on Sat Dec 16 01:28:25 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)